Timely referral to kidney transplant may improve survival for patients with lupus nephritis

January 21, 2019

1. Timely referral to kidney transplant may improve survival for patients with lupus nephritis


Abstract: http://annals.org/aim/article/doi/10.7326/M18-1570
Editorial: http://annals.org/aim/article/doi/10.7326/M18-3721
URLs go live when the embargo lifts

Patients with lupus nephritis and end stage renal disease may benefit from timely kidney transplant, as transplantation was associated with a significant increase in survival in a nationwide cohort study. The main reason for the overall survival benefit was fewer deaths due to cardiovascular disease and infections. The findings are published in Annals of Internal Medicine.

The risk for kidney failure from lupus nephritis is high and has not changed in the past 20 years, despite advances in diagnosis and treatment options. While renal transplantation has been associated with improved survival in the all-cause end stage renal disease population, clinicians proceed with caution for patients with lupus nephritis over fears of infection and other post-transplant complications.

Researchers from Massachusetts General Hospital studied a national database comprised of almost all patients with end stage renal disease to assess outcomes of patients with lupus nephritis who initiated dialysis and were placed on the waitlist for a kidney transplant. They found that transplant was associated with a 70 percent reduction in overall risk for death. The survival benefit persisted in key subgroups, including African Americans, Hispanics, and Asians, as well as in both sexes, in all age groups, and throughout the study period.

According to the authors of an accompanying editorial from Tufts Medical Center, these findings are strong and have implications for clinical practice. They say that kidney transplant should be part of the treatment plan for patients with lupus nephritis and should be emphasized before the onset of kidney failure. In addition, they suggest considering wider use of preemptive transplant in this population.

Media contact: For an embargoed PDF, please contact Lauren Evans at laevans@acponline.org. To interview the lead author, April Jorge, MD, please contact AMJorge@mgh.harvard.edu. To speak with the lead editorialist, Nitender Goyal, MD, please contact Sue McGreevey at smcgreevey@partners.org

2. Recurrent strep infection leads to patient's debilitating muscle pain

Abstract: http://annals.org/aim/article/doi/10.7326/L18-0589
URLs go live when the embargo lifts

A patient with recurrent strep infection developed poststreptococcal myalgia and myositis (inflammation of the muscles), characterized by significant muscle pain and weakness. A biopsy confirmed muscle injury. Findings from a case report are published in Annals of Internal Medicine.

Streptococcal disease, or strep throat, has several immunologically mediated complications, including acute rheumatic fever, poststreptococcal glomerulonephritis (inflammation of the kidneys), and erythema nodosum (inflammation of the skin). Strep may have other complications that are less well-recognized.

Clinicians at Amsterdam UMC saw a 34-year-old man for his third episode of debilitating muscle pain after a sore throat. The bouts of severe muscle pain and weakness occurred in 2013, 2016, and 2018, each time following a throat infection. The patient was often unable to walk without assistance, but symptoms cleared up after a course of antibiotics and considering it was the third episode, the clinicians recommended starting penicillin prophylaxis.

According to the authors, 18 cases of postreptococcal polymyalgia and myositis have been published. Their case is unique because it is the only one with multiple recurrences, it is the only case with myositis confirmed by muscle biopsy, and it is the only one with laboratory signs of muscle injury. The authors suggest that treatment for patients with this type of strep complication could include high-dose acetylsalicylic acid, nonsteroidal anti-inflammatory drugs, penicillin, and prednisone.

Media contact: For an embargoed PDF, please contact Lauren Evans at laevans@acponline.org. To interview the lead author, Marije K. Bomers, MD, PhD, please contact her PR office at communicatie@vumc.nl.
-end-
Also New in this issue: Perfect Compliance: The 2018 Accreditation Council for Graduate Medical Education Well-Being Survey
Christina M. Yuan, MD
Ideas and Opinions
Abstract: http://annals.org/aim/article/doi/10.7326/M18-2302

Caring for Patients With Multiple Chronic Conditions

Mary E. Tinetti, MD; Ariel R. Green, MD, MPH; Jennifer Ouellet, MD; Michael W. Rich, MD; and Cynthia Boyd, MD, MPH
Ideas and Opinions
Abstract: http://annals.org/aim/article/doi/10.7326/M18-3269

American College of Physicians

Related Kidney Transplant Articles from Brightsurf:

The effects of social determinants of health on kidney transplant candidates
Social determinants of health are associated with patient-reported outcomes in adults who are eligible to undergo kidney transplantation evaluations.

Tailored education system to benefit kidney transplant patients
Researchers find their computer-tailored education system, 'Your Path to Transplant' increases knowledge and readiness to pursue kidney transplant.

Kidney transplant, the cost of accounting for patients' preferences
Taking into account patients' preferences can help speed up the organ allocation process and improve the life quality of the recipients, as shown by a joint study conducted by Ca' Foscari University and the University of Padua

New hope for kidney revival for transplant
Cell therapy delivered directly to the kidney can revive a 'marginal' organ, improving function and could offer new hope for providing more kidneys for transplant.

Are kidney transplant patients at higher risk? The European experience
The risk of death is relatively high in kidney transplant patients admitted to hospital with COVID-19.

The economic burden of kidney transplant failure in the United States
A recent analysis published in the American Journal of Transplantation estimates that for the average US patient who has undergone kidney transplantation, failure of the transplanted organ (graft failure) will impose additional medical costs of $78,079 and a loss of 1.66 quality-adjusted life years.

Mixed chimerism improves long-term kidney transplant outlook
Mixed chimerism - the continued mixing of donor and recipient blood cells following a transplant of blood progenitor cells - could improve outcomes for kidney transplant recipients, according to a new clinical study in about 50 patients.

Kidney paired donation is an excellent option for transplant candidates
An analysis compared transplant recipients who received kidneys through national kidney paired donation and those who received kidneys from other living donors (such as relatives, friends or other paired exchange mechanisms).

Mediterranean diet may help preserve the kidney health of transplant recipients
In a study of kidney transplant recipients, those with higher adherence to the Mediterranean diet were less likely to experience kidney function loss.

New blood test can detect rejection by antibodies after kidney transplant
A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies.

Read More: Kidney Transplant News and Kidney Transplant Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.